Noubar Afeyan, Ph.D., 63 Director since: 2010 Chairman since: 2012 Term expires: 2028 2025 Attendance: 100% Committees None Education B.S. in Chemical Engineering from McGill University Ph.D. in Biochemical Engineering from the Massachusetts Institute of Technology Why this director is valuable to Moderna Dr. Afeyan provides strategic expertise and vision as one of our co-founders and as our Chairman since 2012. He has decades of experience co-founding, leading and investing in numerous successful biotechnology companies, applying scientific insights to medical and commercial uses. This experience helps guide our strategy as we continue to explore ways to expand our platform and as we reimagine the ways in which we can impact patients. Dr. Afeyan s experience leading several public and private company boards provides him with valuable leadership experience as the Chairman of our Board. Other Public Boards Generate Biomedicines, Inc. (2018 to present), Chair Omega Therapeutics, Inc. (2016-2023), Chair Rubius Therapeutics, Inc. (2013-2022) Dr. Afeyan is the founder and CEO of Flagship Pioneering, a company that creates bioplatform companies to transform human health and sustainability. An entrepreneur and biochemical engineer, Dr. Afeyan holds more than 100 patents and has co-founded more than 100 life science and technology startups during his career. Dr. Afeyan entered biotechnology during its emergence as an academic field and industry, completing his doctoral work in biochemical engineering at MIT in 1987. He was a senior lecturer at MIT s Sloan School of Management from 2000 to 2016, a lecturer at Harvard Business School until 2020, and he currently serves as a member of the MIT Corporation. In 2022, Dr. Afeyan was elected to the U.S. National Academy of Engineering.